The Food and Drug Administration approved the first fecal microbiota product taken orally to prevent recurrent C. difficile infection. 

“Today’s approval provides patients and healthcare providers a new way to help prevent recurrent C. difficile infection,” said Peter Marks, M.D., director of the FDA’s Center for Biologics Evaluation and Research. “The availability of a fecal microbiota product that can be taken orally is a significant step forward in advancing patient care and accessibility for individuals who have experienced this disease that can be potentially life-threatening.”

Headline
The Centers for Disease Control and Prevention announced today that there are now 1,487 confirmed measles cases nationwide so far this year. The CDC said 5% of…
Headline
The Centers for Disease Control and Prevention released a report March 12 on the effectiveness of the flu vaccine for the 2025-2026 flu season, finding that it…
Headline
The South Carolina Department of Public Health March 6 reported that the state’s measles outbreak is at 991 cases. The agency said the vaccination status of…
Headline
The South Carolina Department of Public Health reported Feb. 27 that the state’s measles outbreak is at 985 cases, up six cases from Feb. 24. Nationally, there…
Headline
The Centers for Disease Control and Prevention Feb. 26 announced that an infant botulism outbreak that sickened 48 babies who consumed ByHeart formula is over…
Headline
The measles outbreak in South Carolina has increased to 979 cases, the state’s Department of Public Health reported Feb. 24. The agency said there have been 21…